The company reported results from preclinical research demonstrating that antibodies directed to a potential new target, angiopoietin-like protein 4 (ANGPTL4), rapidly lower triglycerides and cholesterol. Research suggests that
The FDA originally proposed its “black box warning” about anaphylaxis back in February. The label’s final wording has only recently been announced. Xolair, which is known generically as
The product, which is for the treatment of fungal infections, is available in bottles of 30 tablets and 100 tablets for immediate shipment to wholesalers and pharmacies nationwide.
Terbinafine HCl Tablets are the generic version of Novartis’ Lamisil tablets, which are used for fungal infections. Terbinafine HCl tablets had US sales of approximately $685 million for
The company claims that the drug, MAXY-G34, is a novel pegylated granulocyte colony stimulating factor (PEG-GCSF) shown in preclinical and phase I studies to have novel and potentially
The new formulation utilizes SkyePharma’s patented Geomatrix technology, which has been developed to provide a lower dose of Sular for each of its current doses. Sular is designed
According to the company, these results are the first that describe the protective immunity elicited by a multivalent vaccine that is active by the mucosal route. The vaccine
The companies say lixivaptan is a selective V2 vasopressin receptor antagonist that, in clinical trials, has demonstrated promising activity in treating hyponatremia, an imbalance of sodium and water
Researchers at the University of Pennsylvania tested CSA-13 in treating multidrug resistant pseudomonas aeuroginosa infections, which are a leading cause of morbidity and mortality in patients with cystic
The drug, ALX-0081, uses the company’s Nanobody technology to target to reduce the risk of thrombosis in patients with acute coronary syndrome. The phase I study in healthy
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.